Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)
Technical Analysis Report for NASDAQ stock BOLD Audentes Therapeutics. Dated: 19 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics
Audentes Therapeutics Opened at 1.28 and Closed at: 1.22, which is -4.1% of previous session's close. It moved within a range of 1.22 and 1.30
The session was a Bearish session with an average volume of 88600, which is -468.74% of previous session's volumes.
A Golden cross was found 4 days back on short term averages
Support for tomorrow is 1.18 and resistance for tomorrow is 1.26
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.19, 1.17 resistance for tomorrow's hourly charts is 1.27, 1.33
10 Day SMA for Audentes Therapeutics (BOLD) is 1.18 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Audentes Therapeutics (BOLD) is 1.15 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Audentes Therapeutics (BOLD) is 1.25 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.21 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Audentes Therapeutics is 1.27 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Audentes Therapeutics is at 1.15 and 200 DMA is at 1.27, while 50 DMA and 100 DMA are at 1.25 and 1.21 respectively
Audentes Therapeutics (BOLD) moving average of 20 SMA is at 1.15 and 20 EMA is at 1.19
| Date | Closing Price | 20 SMA | 20 EMA |
| 19 Fri Dec | 1.22 | 1.15 | 1.19 |
| 18 Thu Dec | 1.27 | 1.14 | 1.19 |
| 17 Wed Dec | 1.27 | 1.14 | 1.18 |
| 16 Tue Dec | 1.14 | 1.13 | 1.17 |
| 15 Mon Dec | 1.14 | 1.14 | 1.17 |
| 12 Fri Dec | 1.17 | 1.14 | 1.17 |
Audentes Therapeutics (BOLD) moving average of 50 SMA is at 1.25 and 50 EMA is at 1.22
| Date | Closing Price | 50 SMA | 50 EMA |
| 19 Fri Dec | 1.22 | 1.25 | 1.22 |
| 18 Thu Dec | 1.27 | 1.25 | 1.22 |
| 17 Wed Dec | 1.27 | 1.25 | 1.22 |
| 16 Tue Dec | 1.14 | 1.25 | 1.22 |
| 15 Mon Dec | 1.14 | 1.25 | 1.22 |
| 12 Fri Dec | 1.17 | 1.26 | 1.22 |
Audentes Therapeutics (BOLD) moving average of 100 SMA is at 1.21 and 100 EMA is at 1.33
| Date | Closing Price | 100 SMA | 100 EMA |
| 19 Fri Dec | 1.22 | 1.21 | 1.33 |
| 18 Thu Dec | 1.27 | 1.21 | 1.33 |
| 17 Wed Dec | 1.27 | 1.21 | 1.33 |
| 16 Tue Dec | 1.14 | 1.21 | 1.33 |
| 15 Mon Dec | 1.14 | 1.21 | 1.33 |
| 12 Fri Dec | 1.17 | 1.21 | 1.33 |
Audentes Therapeutics (BOLD) moving average of 200 SMA is at 1.27 and 200 EMA is at 1.6
| Date | Closing Price | 200 SMA | 200 EMA |
| 19 Fri Dec | 1.22 | 1.27 | 1.6 |
| 18 Thu Dec | 1.27 | 1.27 | 1.6 |
| 17 Wed Dec | 1.27 | 1.28 | 1.6 |
| 16 Tue Dec | 1.14 | 1.28 | 1.6 |
| 15 Mon Dec | 1.14 | 1.28 | 1.6 |
| 12 Fri Dec | 1.17 | 1.29 | 1.6 |
Xbiotech Inc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Xbiotech Inc, about 1.69% more returns!
Audentes Therapeutics has performed better than Vistagen Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Veru Inc in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Urogen Pharma in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Tiziana Life in short term. Holding Audentes Therapeutics could be a better choice for now!
Quidel Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Quidel Corporation, about 10.93% more returns!
Audentes Therapeutics has performed better than Prothena Corporation in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Adial Pharmaceuticals in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Aptorum Group in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Ascendis Pharma in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Catalyst Biosciences in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Cidara Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!
Cogentix Medical has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Cogentix Medical, about 10% more returns!
Audentes Therapeutics has performed better than Ensign Group in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Guardant Health in short term. Holding Audentes Therapeutics could be a better choice for now!
Healthcare Services has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Healthcare Services, about 0.78% more returns!
Audentes Therapeutics has performed better than Immuron in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics Technical analysis of indicators
Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Audentes Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Audentes Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Audentes Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Audentes Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.22 and Audentes Therapeutics BOLD stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.
Audentes Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BOLD Experts View which covers a lot of information including buying and selling signals
BOLD future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


